Innovation Policy and the Economy Working Group

w21597 William R. Kerr
Martin Mandorff

Social Networks, Ethnicity, and Entrepreneurship

w21579 Mikko Packalen
Jay Bhattacharya

Neophilia Ranking of Scientific Journals

w21522 Xing Li
Megan MacGarvie
Petra Moser

Dead Poet's Property - How Does Copyright Influence Price?

w21514 Yuriy Gorodnichenko
Jan Svejnar
Katherine Terrell

Does Foreign Entry Spur Innovation?

w21507 Jamal Ibrahim Haidar
Takeo Hoshi

Implementing Structural Reforms in Abenomics: How to Reduce the Cost of Doing Business in Japan

w21496 Liran Einav
Chiara Farronato
Jonathan Levin

Peer-to-Peer Markets

w21479 Adam B. Jaffe
Trinh Le

The Impact of R&D Subsidy on Innovation: a Study of New Zealand Firms

w21458 Sari Kerr
William R. Kerr
Ramana Nanda

House Money and Entrepreneurship

w21455 Bronwyn H. Hall
Christian Helmers
Georg von Graevenitz

Technology Entry in the Presence of Patent Thickets

w21443 Petra Moser
Joerg Ohmstedt
Paul W. Rhode

Patent Citations and the Size of the Inventive Step - Evidence from Hybrid Corn

w21378 Siqi Zheng
Weizeng Sun
Jianfeng Wu
Matthew E. Kahn

The Birth of Edge Cities in China: Measuring the Spillover Effects of Industrial Parks

w21375 B. Zorina Khan
Inventing Prizes: A Historical Perspective on Innovation Awards and Technology Policy

w21267 Andrew W. Lo
The Gordon Gekko Effect: The Role of Culture in the Financial Industry

w21247 Philippe Aghion
Ufuk Akcigit
Antonin Bergeaud
Richard Blundell
David Hémous

Innovation and Top Income Inequality

w21246 Heidi L. Williams
Intellectual Property Rights and Innovation: Evidence from Health Care Markets

w21239 Frank R. Lichtenberg
The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011

w21196 Sunil Kanwar
Bronwyn H. Hall

The Market Value of R&D in Weak Innovation Regimes: Evidence from India

w21175 Giovanni Peri
Kevin Shih
Chad Sparber

Foreign and Native Skilled Workers: What Can We Learn from H-1B Lotteries?

w21146 Pierre Azoulay
Alessandro Bonatti
Joshua L. Krieger

The Career Effects of Scandal: Evidence from Scientific Retractions

w21143 Bralind Kiri
Nicola Lacetera
Lorenzo Zirulia

Above a Swamp: A Theory of High-Quality Scientific Production

w21134 Ajay Agrawal
Christian Catalini
Avi Goldfarb

Slack Time and Innovation

w21105 Roland Bénabou
Davide Ticchi
Andrea Vindigni

Forbidden Fruits: The Political Economy of Science, Religion, and Growth

w21090 Alexander Galetovic
Stephen Haber
Ross Levine

An Empirical Examination of Patent Hold-up

w21012 Michael Kremer
Christopher Snyder

Preventives Versus Treatments

w20995 María José Abud Sittler
Bronwyn Hall
Christian Helmers

An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile

w20969 Richard G. Newell
Juha V. Siikamaki

Individual Time Preferences and Energy Efficiency

w20954 Jorge Guzman
Scott Stern

Nowcasting and Placecasting Entrepreneurial Quality and Performance

w20922 Mikko Packalen
Jay Bhattacharya

New Ideas in Invention

w20921 Mikko Packalen
Jay Bhattacharya

Cities and Ideas

w20920 Mikko Packalen
Jay Bhattacharya

Age and the Trying Out of New Ideas

w20902 Ashish Arora
Sharon Belenzon
Andrea Patacconi

Killing the Golden Goose? The Decline of Science in Corporate R&D

w20889 Pierre Azoulay
Joshua S. Graff Zivin
Danielle Li
Bhaven N. Sampat

Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules

w20878 Leila Agha
David Molitor

The Local Influence of Pioneer Investigators on Technology Adoption: Evidence from New Cancer Drugs

w20867 David H. Howard
Peter B. Bach
Ernst R. Berndt
Rena M. Conti

Pricing in the Market for Anticancer Drugs

w20854 B. Zorina Khan
Invisible Women: Entrepreneurship, Innovation and Family Firms in France during Early Industrialization

w20846 Mu-Jeung Yang
Lorenz Kueng
Bryan Hong

Business Strategy and the Management of Firms

w20743 Daron Acemoglu
Ufuk Akcigit
Douglas Hanley
William Kerr

Transition to Clean Technology

w20732 B. Zorina Khan
Of Time and Space: Technological Spillovers among Patents and Unpatented Innovations during Early U.S. Industrialization

w20731 B. Zorina Khan
Inventing in the Shadow of the Patent System: Evidence from 19th-Century Patents and Prizes for Technological Innovations

w20683 Julia Lane
Jason Owen-Smith
Rebecca Rosen
Bruce Weinberg

New Linked Data on Research Investments: Scientific Workforce, Productivity, and Public Value

w20676 William R. Kerr
Ramana Nanda

Financing Innovation

w20670 Joseph E. Stiglitz
Unemployment and Innovation

w20668 Kirk Doran
Alexander Gelber
Adam Isen

The Effects of High-Skilled Immigration Policy on Firms: Evidence from H-1B Visa Lotteries

w20621 Lorenz Kueng
Mu-Jeung Yang
Bryan Hong

Sources of Firm Life-Cycle Dynamics: Differentiating Size vs. Age Effects

w20615 Ajay Agrawal
Carlos Rosell
Timothy S. Simcoe

Do Tax Credits Affect R&D Expenditures by Small Firms? Evidence from Canada

w20587 Yael V. Hochberg
Carlos J. Serrano
Rosemarie H. Ziedonis

Patent Collateral, Investor Commitment, and the Market for Venture Lending

w20548 Mark Duggan
Craig Garthwaite
Aparajita Goyal

The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India

w20532 Lee Branstetter
Chirantan Chatterjee
Matthew J. Higgins

Starving (or Fattening) the Golden Goose?: Generic Entry and the Incentives for Early-Stage Pharmaceutical Innovation

w20521 Richard B. Freeman
Immigration, International Collaboration, and Innovation: Science and Technology Policy in the Global Economy

w20379 John Komlos
Has Creative Destruction Become More Destructive?

w20375 Mercedes Delgado
Michael E. Porter
Scott Stern

Defining Clusters of Related Industries

w20367 Gerald Carlino
William R. Kerr

Agglomeration and Innovation

w20364 Joshua S. Gans
Remix Rights and Negotiations Over the Use of Copy-Protected Works

w20358 William R. Kerr
Ramana Nanda
Matthew Rhodes-Kropf

Entrepreneurship as Experimentation

w20292 Keith M. Drake
Martha A. Starr
Thomas McGuire

Do "Reverse Payment" Settlements of Brand-Generic Patent Disputes in the Pharmaceutical Industry Constitute an Anticompetitive Pay for Delay?

w20269 Alberto Galasso
Mark Schankerman

Patents and Cumulative Innovation: Causal Evidence from the Courts

w20212 David Dranove
Craig Garthwaite
Manuel Hermosilla

Pharmaceutical Profits and the Social Value of Innovation

w20102 Nicholas Bloom
Renata Lemos
Raffaella Sadun
Daniela Scur
John Van Reenen

The New Empirical Economics of Management

w20069 Sari Pekkala Kerr
William R. Kerr
William F. Lincoln

Firms and the Economics of Skilled Immigration

w20039 Hezekiah Agwara
Philip Auerswald
Brian Higginbotham

Algorithms and the Changing Frontier

w20037 Annamaria Conti
Christopher C. Liu

The (Changing) Knowledge Production Function: Evidence from the MIT Department of Biology for 1970-2000

w20036 Chris Forman
Avi Goldfarb
Shane Greenstein

Information Technology and the Distribution of Inventive Activity

w20016 Rena M. Conti
Ernst R. Berndt

Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007

w20012 Ajay K. Agrawal
John McHale
Alex Oettl

Why Stars Matter

w19962 Petra Moser
Alessandra Voena
Fabian Waldinger

German-Jewish Emigres and U.S. Invention

w19951 Nicholas Bloom
Paul M. Romer
Stephen J. Terry
John Van Reenen

Trapped Factors and China's Impact on Global Growth

w19894 Daron Acemoglu
Ufuk Akcigit
Murat Alp Celik

Young, Restless and Creative: Openness to Disruption and Creative Innovations

w19868 Ejaz Ghani
William R. Kerr
Stephen D. O'Connell

Political Reservations and Women's Entrepreneurship in India

w19866 Benjamin Jones
E.J. Reedy
Bruce A. Weinberg

Age and Scientific Genius

w19819 Richard B. Freeman
Ina Ganguli
Raviv Murciano-Goroff

Why and Wherefore of Increased Scientific Collaboration

Generated Sat Oct 10 00:00:18 2015

NBER Videos

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email:

Contact Us